Bone Marrow (BM) May be More Informative Than Peripheral...

Clinical Lymphoma Myeloma and Leukemia 2014 / 09 Vol. 14

Bone Marrow (BM) May be More Informative Than Peripheral Blood (PB) to Evaluate Minimal Residual Disease (MRD) During 1st and 2nd Year Follow up After First-line Fludarabine, Cyclophosphamide, and Rituximab (FCR) for Chronic Lymphocytic Leukemia (CLL)

Strati, Paolo, Keating, Michael J., O'Brien, Susan M., Burger, Jan, Ferrajoli, Alessandra, Jain, Nitin, Estrov, Zeev, Jorgensen, Jeffrey, Faderl, Stefan H., Wierda, William G.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2014.06.065
Date:
September, 2014
File:
PDF, 230 KB
english, 2014
Conversion to is in progress
Conversion to is failed